We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Baxter Ad for Hemostatic Tisseel Cited for Efficacy Claim
Baxter Ad for Hemostatic Tisseel Cited for Efficacy Claim
May 8, 2009
The FDA issued a warning letter to Baxter International over promotional materials used to market the company’s fibrin sealant Tisseel, a hemostat indicated for use in controlling bleeding in cardiopulmonary bypass and spleen injury surgeries.